Prenatal Screening and Diagnostic Considerations for 22q11.2 Microdeletions

Natalie Blagowidow1, Beata Nowakowska2, Erica Schindewolf3

  • 1Harvey Institute for Human Genetics, Greater Baltimore Medical Center, Baltimore, MD 21204, USA.

Genes
|January 21, 2023
PubMed
Summary

Early diagnosis of 22q11.2 deletion syndrome (22q11.2DS) is crucial. This review offers guidance on prenatal screening and diagnostic testing for 22q11.2DS, emphasizing genetic counseling for optimal perinatal care.